Avalo Therapeutics, Inc.
AVTX· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q4 2015 | Q4 2014 |
|---|---|---|
| Net Income | -$3.65M | -$2.52M |
| EPS Diluted | -$0.53 | -$3.88 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Avalo Therapeutics, Inc. · CIK 1534120 · Engraved from SEC EDGAR